JPS62209010A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPS62209010A JPS62209010A JP5337386A JP5337386A JPS62209010A JP S62209010 A JPS62209010 A JP S62209010A JP 5337386 A JP5337386 A JP 5337386A JP 5337386 A JP5337386 A JP 5337386A JP S62209010 A JPS62209010 A JP S62209010A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- moisture
- retaining
- cosmetics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 28
- 229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 12
- 230000000694 effects Effects 0.000 abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 10
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract description 3
- 210000002969 egg yolk Anatomy 0.000 abstract description 3
- 229920002674 hyaluronan Polymers 0.000 abstract description 3
- 229960003160 hyaluronic acid Drugs 0.000 abstract description 3
- 229910017053 inorganic salt Inorganic materials 0.000 abstract description 3
- 229910052749 magnesium Inorganic materials 0.000 abstract description 3
- -1 soybean lecithin Chemical class 0.000 abstract description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 abstract description 2
- 229910052791 calcium Inorganic materials 0.000 abstract description 2
- 239000000787 lecithin Substances 0.000 abstract description 2
- 235000010445 lecithin Nutrition 0.000 abstract description 2
- 229940067606 lecithin Drugs 0.000 abstract description 2
- 229910052751 metal Inorganic materials 0.000 abstract description 2
- 239000002184 metal Substances 0.000 abstract description 2
- 229940083466 soybean lecithin Drugs 0.000 abstract description 2
- 239000000654 additive Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 230000002633 protecting effect Effects 0.000 abstract 1
- 238000007788 roughening Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 17
- 230000003020 moisturizing effect Effects 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 9
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 210000000434 stratum corneum Anatomy 0.000 description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 229920002567 Chondroitin Polymers 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 3
- 235000019799 monosodium phosphate Nutrition 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 3
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 3
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 3
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- VFNGKCDDZUSWLR-UHFFFAOYSA-L disulfate(2-) Chemical compound [O-]S(=O)(=O)OS([O-])(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-L 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 2
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229940042880 natural phospholipid Drugs 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、新規な化粧料に関し、さらに詳しくは、ムコ
多糖類と、リン脂質と、無機塩類とを必須に含有するこ
とを特徴とする化粧料に関するものである。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to a novel cosmetic, and more specifically, the present invention is characterized in that it essentially contains a mucopolysaccharide, a phospholipid, and an inorganic salt. It is related to cosmetics.
本発明の目的とするところは、皮膚の乾燥、肌荒れを防
止し、皮膚に弾力性、柔軟性を賦与する、保湿効果並び
に皮膚の保護効果の優れた化粧料を提供することにある
。An object of the present invention is to provide a cosmetic that prevents skin dryness and roughness, imparts elasticity and flexibility to the skin, and has excellent moisturizing and skin protective effects.
[従来の技術]
皮膚における保湿のメカニズムについては、複雑な因子
が絡む為、未だ不明な点が多く残されているが、その中
で角質層の水分量は、角質層がその形態・機能を維持す
る為の重要な因子であり、健康な皮膚の角質層において
は1体内外からの水分供給と皮膚からの水分蒸発とのバ
ランスによって適度の水分量が保たれている。[Conventional technology] The mechanism of moisturization in the skin is still unclear due to the involvement of complex factors. Among these, the amount of water in the stratum corneum is a function of the structure and function of the stratum corneum. In the stratum corneum of healthy skin, an appropriate amount of water is maintained through a balance between water supply from inside and outside the body and water evaporation from the skin.
しかし、皮脂分泌の少ない乾燥肌の人や、季箇の変化等
でこのバランスが崩れた場合には、角質層の水分量が減
少して皮膚がかさつき、極端な場合にはひびやあかぎれ
を生ずることがある。However, for people with dry skin that secretes little sebum, or when this balance is disrupted due to seasonal changes, the moisture content of the stratum corneum decreases, causing the skin to become dry and, in extreme cases, to develop cracks and chapped skin. This may occur.
このような観点から、一般に、角質層の水分量を保つ為
に、グリセリン、ピロ゛リドンカルボン酸ナトリウム、
乳酸ナトリウム等の保湿剤を配合した化粧料が用いられ
てきた。From this point of view, in order to maintain the moisture content of the stratum corneum, glycerin, sodium pyrrolidone carboxylate,
Cosmetics containing moisturizing agents such as sodium lactate have been used.
また、従来、ムコ多糖類、アラントイン、コラーゲンや
、種々の植物抽出物等を、肌荒れ防止、創傷治i等の効
果を有するとして、化粧料に配合する試みがなされてき
た(特開昭57−183707、80−1113819
他)。In addition, attempts have been made to incorporate mucopolysaccharides, allantoin, collagen, and various plant extracts into cosmetics as having effects such as preventing rough skin and healing wounds (Japanese Patent Laid-Open Publication No. 1983-1999-1). 183707, 80-1113819
other).
一方、リン脂質は、生体膜の構成成分とじて古くから知
られているが、両親媒性物質であることから、乳化剤と
して化粧料への応用も種々検討されてきた。On the other hand, phospholipids have been known for a long time as constituents of biological membranes, but since they are amphiphilic substances, various applications have been investigated as emulsifiers in cosmetics.
[発明が解決しようとする問題点]
しかしながら、いわゆる保湿剤は、水分を角質層に供給
するという機能は有するが、一時的な効果しかなく、し
かも低湿度環境下では、逆に角質層から水分を奪うとい
う欠点を有している。[Problems to be Solved by the Invention] However, although so-called humectants have the function of supplying moisture to the stratum corneum, they only have a temporary effect, and moreover, in a low-humidity environment, they conversely remove moisture from the stratum corneum. It has the disadvantage of depriving you of
また、ムコ多糖類、アラントイン、コラーゲンや、植物
抽出物等は、前記の如く優れた美容効果を有するもので
あるが、未だ満足すべき保湿効果を有するものが得られ
ておらず、種々研究されているのが現状である。In addition, mucopolysaccharides, allantoin, collagen, plant extracts, etc. have excellent beauty effects as mentioned above, but nothing with satisfactory moisturizing effects has yet been obtained, and various studies have been conducted. The current situation is that
[問題点を解決するための手段]
本発明者等は、係る点に鑑み、優れた保湿効果を有する
化粧料を得るべく鋭意研究した結果、ムコ多糖類と、リ
ン脂質と、無機塩類とを必須に配合することにより、極
めて顕著な保湿効果が得られることを見出し、本発明を
完成するに到った。[Means for Solving the Problems] In view of the above points, the present inventors conducted intensive research to obtain cosmetics with excellent moisturizing effects, and as a result, they discovered that mucopolysaccharides, phospholipids, and inorganic salts It was discovered that an extremely significant moisturizing effect can be obtained by essential blending, and the present invention was completed.
すなわち、本発明は、ムコ多糖類と、リン脂質と、無機
塩類とを必須に含有することを特徴とし、保湿効果に優
れ、また皮膚の保護効果を有する化粧料を提供するもの
である。That is, the present invention provides a cosmetic composition that essentially contains mucopolysaccharides, phospholipids, and inorganic salts, and has an excellent moisturizing effect and a skin protective effect.
本発明において使用されるムコ多糖類としては、ヒアル
ロン酸、ヒアルロン酸−蛋白複合体、コンドロイチン4
硫酸、コンドロイチン6硫酸、コンドロイチン4,6ジ
硫酸、デルマタン硫酸、ダルマタン4.8ジ硫酸、ケラ
タン硫酸、ヘパラン硫酸、キチン等と、これらの塩類並
びに誘導体が挙げられる。ムコ多糖類は皮膚の構成成分
の一種であり、動物由来、全生物由来。The mucopolysaccharides used in the present invention include hyaluronic acid, hyaluronic acid-protein complex, chondroitin 4
Examples include sulfuric acid, chondroitin hexasulfate, chondroitin 4,6 disulfate, dermatan sulfate, darmatan 4.8 disulfate, keratan sulfate, heparan sulfate, chitin, and their salts and derivatives. Mucopolysaccharides are a type of skin component and are derived from animals and all living organisms.
合成品の何れでも用い得る。すなわち、起源や抽出方法
、精製処理方法は特に限定されるものではない。Any synthetic product can be used. That is, the origin, extraction method, and purification method are not particularly limited.
化粧料中におけるムコ多糖類の配合量は、少なすぎる場
合は効果がなく、0.0001〜5.0重量%の範囲が
使用感上も好ましく、本発明の目的の為には十分である
が、0.001〜3.0重量%の範囲であればより好ま
しい。If the amount of mucopolysaccharide in the cosmetic is too small, it will not be effective, and a range of 0.0001 to 5.0% by weight is preferable from the viewpoint of feeling of use, and is sufficient for the purpose of the present invention. , more preferably in the range of 0.001 to 3.0% by weight.
また、本発明において使用されるリン脂質としては、大
豆や卵黄等から抽出される天然のリン脂質(レシチン)
やその水素添加物、さらに、その分離精製、また合成さ
れたホスファチジルコリン、ホスファチジルエタノール
アミン、スフィンゴミエリン等と、その誘導体が挙げら
れる。In addition, the phospholipids used in the present invention include natural phospholipids (lecithin) extracted from soybeans, egg yolks, etc.
Examples include phosphatidylcholine, phosphatidylethanolamine, sphingomyelin, etc., and derivatives thereof.
化粧料中におけるリン脂質の配合量は、o、ooot〜
5.0重量%の範囲が本発明にとって効果的であるが、
0.001〜2.0重量%の範囲であればより好ましい
。The amount of phospholipid in cosmetics is o, ooot ~
Although a range of 5.0% by weight is effective for the present invention,
More preferably, the content is in the range of 0.001 to 2.0% by weight.
さらに本発明において必須に配合される無機塩類は、ナ
トリウム、カリウム、カルシウム、マグネシウム等の一
価または二価の金属の生理的に許容される塩類であり、
塩化ナトリウム、塩化カリウム、塩化カルシウム、塩化
マグネシウム、t!酸マグネシウム、炭酸水素ナトリウ
ム、リン酸水素二ナトリウム、リン酸二水素ナトリウム
、リン酸二水素カリウム等が挙げられる。Furthermore, the inorganic salts that are essential in the present invention are physiologically acceptable salts of monovalent or divalent metals such as sodium, potassium, calcium, and magnesium.
Sodium chloride, potassium chloride, calcium chloride, magnesium chloride, t! Examples include magnesium acid, sodium hydrogen carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, potassium dihydrogen phosphate, and the like.
化粧料中における無機1M類の配合量は、0.01〜5
.0重量%の範囲とするのが効果的であり。The amount of inorganic 1M in cosmetics is 0.01 to 5.
.. A range of 0% by weight is effective.
かつ化粧料中の他成分との相互作用による悪影響等もな
く、好ましい、また、上記無機塩類の他に1通常生理的
塩類溶液の成分として用いられるグルコース等の他の成
分を配合することも1本発明の効果を妨げるものではな
い。Moreover, there is no adverse effect due to interaction with other ingredients in cosmetics, which is preferable. In addition to the above-mentioned inorganic salts, it is also possible to incorporate other ingredients such as glucose, which is usually used as a component of physiological saline solutions. This does not impede the effects of the present invention.
上記無機塩類の化粧料への配合の際には、無機塩類の一
種または二種以上を1個々に配合しても、また、予め精
製水に溶解させたものを調製して配合しても良く、配合
方法は特に限定しない、上記無機塩類の溶液のpHは、
4,0〜8.0の範囲とするのが、肌への刺激等もなく
。When blending the above-mentioned inorganic salts into cosmetics, one or more of the inorganic salts may be blended individually, or they may be dissolved in purified water in advance and blended. , the blending method is not particularly limited, and the pH of the solution of the above inorganic salts is:
A range of 4.0 to 8.0 will not irritate the skin.
適当である。Appropriate.
本発明の化粧料は、上記の如くムコ多糖類と、リン脂質
と、無機IpA類とを必須に含有することを特徴とする
ものであるが、これに加えて、通常化粧料に用いられる
界面活性剤、油分、保湿剤、紫外線吸収剤、アルコール
類、キレート剤、pH7A整剤、防腐剤、増粘剤1色素
、香料等を必要に応じ適宜配合し得る。The cosmetics of the present invention are characterized by essentially containing mucopolysaccharides, phospholipids, and inorganic IpAs as described above, but in addition, they also contain an interface commonly used in cosmetics. Active agents, oils, humectants, ultraviolet absorbers, alcohols, chelating agents, pH7A adjusters, preservatives, thickeners, pigments, fragrances, and the like may be blended as appropriate.
本発明でいう化粧料とは、皮膚の保護を目的とした化粧
料であり、特にスキンローション、カラミンローション
、アストリンゼンドロージョン、ヘアローション、ボデ
ィローション等の水性化粧料として用いられるものであ
る。The cosmetics referred to in the present invention are cosmetics intended for skin protection, and are particularly used as aqueous cosmetics such as skin lotions, calamine lotions, astringent lotions, hair lotions, and body lotions.
[実施例]
次に、本発明について、実施例を挙げてさらに説明する
。これらは本発明を何ら限定するものではない。[Example] Next, the present invention will be further explained by giving examples. These do not limit the present invention in any way.
まず、表1に処方を示す実施例[1]及び比較例 [1
1〜[71の8種の試料(化粧水)を、通常の方法で調
製し、保湿効果の測定及び官能検査を行って、その効果
を比較した。First, Example [1] and Comparative Example [1] whose prescriptions are shown in Table 1.
Eight types of samples (toners), Nos. 1 to 71, were prepared in a conventional manner, and their moisturizing effects were measured and subjected to a sensory test to compare their effects.
なお、表中の値は重量%を示す。In addition, the values in the table indicate weight %.
(以下余白)
表1
表 1(続き)
i)保湿効果の測定
20〜40才の女性20名を被験者とし、左右前腕屈側
部各4箇所を試験部位として、各試験部位に、各サンプ
ルを1日に朝、晩2回塗布した。なお、使用期間は冬期
の2週間とした。(Margins below) Table 1 Table 1 (Continued) i) Measurement of moisturizing effect 20 women aged 20 to 40 were used as test subjects. Four test sites each were placed on the flexor sides of the left and right forearms. Each sample was applied to each test site. It was applied twice a day, in the morning and in the evening. The period of use was two weeks during the winter season.
上記の塗布期間終了後、インピーダンスメーター(1,
B、S、株式会社製、モデル1.8゜355)を用いて
試験部位の電気伝導度を測定した。伝導度の値が大きい
程角質層中の水分量が多いことを示す。After the above application period is over, use the impedance meter (1,
The electrical conductivity of the test site was measured using a model 1.8°355 (manufactured by B, S, Co., Ltd.). The higher the conductivity value, the higher the amount of water in the stratum corneum.
判定は以下の如く各人について点数をつけることによっ
て行い、点数の総和を評価点と −9して求めた。Judgment was made by assigning a score to each person as shown below, and the total score was calculated as an evaluation score of -9.
表2に、各ランクに判定された人数と、評画点とを示す
。Table 2 shows the number of people judged to be in each rank and the rating points.
表2 評価結果
ii )官能評価
20〜40才の乾燥肌の女性48名を被験者とし、各群
78計7群として、各群lサンプルで実施例[1]及び
比較例 [11〜[Etlの使用テストを行った。評価
は、「肌への弾力性賦与効果」、「しっとり効果」、「
肌荒れ防止効果」の三項目について、比較例[7] を
対照とした相対評価で行い、以下の如く点数をっけ、点
数の総和を評価点として求めた。Table 2 Evaluation results ii) Sensory evaluation 48 women with dry skin between the ages of 20 and 40 were used as subjects, 78 in each group, 7 groups in total. We conducted a usage test. The evaluations were "elasticity imparting effect on the skin", "moisturizing effect", and "
Relative evaluation was carried out using Comparative Example [7] as a control for the three items of ``effect on preventing rough skin'', and the scores were calculated as shown below, and the sum of the scores was determined as the evaluation score.
表3に、各ランクに評価した人数と、評価点とを示す。Table 3 shows the number of people who evaluated each rank and their evaluation scores.
(以下余白)
表3 評価結果
以上の評価結果から明らかな如く、実施例[1]の化粧
水は、ムコ多糖類、リン脂質、無機塩類をそれぞれ単独
、あるいは二種を組み合わせて配合した場合と比較して
顕著な保湿効果を示し、また、しっとり感に富み、肌に
弾力性を与え、肌荒れ防止効果も有するという優れた皮
膚の保護効果も有するものであった。(The following is a blank space) Table 3 Evaluation Results As is clear from the above evaluation results, the lotion of Example [1] contains mucopolysaccharides, phospholipids, and inorganic salts, either alone or in combination. In comparison, it exhibited a remarkable moisturizing effect, and also had an excellent skin protection effect, giving a rich moist feeling, giving elasticity to the skin, and preventing rough skin.
実施例[2]化粧水
(処方) (重量%)で1)
クエン酸 0.1″、2)ク
エン酸ナトリウム 0.4:3)乳酸ナ
トリウム 0.8:4)ピロリドン
カルボン酸ナトリウム 0.8:5) 1.3−ブチ
レングリコール 10.0[B)メチルセルロ
ース(0,5%水溶液)0.8−7)ポリオキシエチレ
ンポリオキシブ 0.20ピレンセチルエーテル(20
E、0. 。Example [2] Lotion (prescription) (wt%) 1)
Citric acid 0.1″, 2) Sodium citrate 0.4:3) Sodium lactate 0.8:4) Sodium pyrrolidonecarboxylate 0.8:5) 1.3-Butylene glycol 10.0 [B) Methyl cellulose ( 0.5% aqueous solution) 0.8-7) Polyoxyethylene polyoxybu 0.20 pyrene cetyl ether (20
E, 0. .
8P、O,)
8)香料 0.019)
卵黄水添レシチン 0.1(10)コン
ドロイチン硫酸ナトリウム 0.001(11)コ
ラーゲン 0.01(12)塩化
ナトリウム 0.04(13)塩化カ
リウム 0.001(14)塩化マ
グネシウム 0.001(15)炭酸
水素ナトリウム 0.005(16)リ
ン酸二水素ナトリウム 0.001(17)
グルコース 0.1(18)精
製水 残量(製法)
A (12)〜(17)を(18)に溶解する。8P, O,) 8) Fragrance 0.019)
Egg yolk hydrogenated lecithin 0.1 (10) Sodium chondroitin sulfate 0.001 (11) Collagen 0.01 (12) Sodium chloride 0.04 (13) Potassium chloride 0.001 (14) Magnesium chloride 0.001 (15) Sodium hydrogen carbonate 0.005 (16) Sodium dihydrogen phosphate 0.001 (17)
Glucose 0.1 (18) Purified water Remaining amount (manufacturing method) A Dissolve (12) to (17) in (18).
B(8)を(5)に溶解する。Dissolve B (8) in (5).
C(1)〜(4) 、 (8) 、 (10)、(11
)をAに混合溶解する。C(1) to (4), (8), (10), (11
) are mixed and dissolved in A.
D (7) 、 (8)を混合溶解し、B、Cと混合
する。Mix and dissolve D (7) and (8) and mix with B and C.
実施例[3] アストリンゼンドロージョン(処方)
(重量%)(1)クエン酸
0・1(2)クエン酸ナトリ
ウム 0.2(3)ピロリドンカルボン
酸ナトリウム 0.5(4)グリセリン
0.5(5)ハマメリス抽出物
2.0(6)エチルアルコール
15.0(7)バラオキシ安息香酸メチル 0
.05(8)香料 0.
01(9)大豆水添レシチン 0.0
5(lO)ヒアルロン酸 0.0
01(11)エラスチン 0.
01(12)塩化ナトリウム 0.
9(13)塩化カリウム 0.04
2(14)塩化カルシウム 0.0
24(15)炭酸水素ナトリウム 0.
02(1G)グルコース 0.
1(17)精製水 残量(製
法)
A (12)〜(16)を(17)に溶解する。Example [3] Astrinsend Lotion (Prescription)
(Weight%) (1) Citric acid
0.1(2) Sodium citrate 0.2(3) Sodium pyrrolidonecarboxylate 0.5(4) Glycerin
0.5 (5) Hamamelis extract
2.0(6) Ethyl alcohol
15.0(7) Methyl roseoxybenzoate 0
.. 05(8) Fragrance 0.
01(9) Soybean hydrogenated lecithin 0.0
5(lO) Hyaluronic acid 0.0
01 (11) Elastin 0.
01(12) Sodium chloride 0.
9(13) Potassium chloride 0.04
2(14) Calcium chloride 0.0
24(15) Sodium hydrogen carbonate 0.
02 (1G) Glucose 0.
1 (17) Purified water remaining amount (manufacturing method) A Dissolve (12) to (16) in (17).
B(9)を(4)に溶解する。Dissolve B (9) in (4).
C(1)〜(3) 、 (5)をAに混合攪拌し、Bと
混合する。C(1) to (3) and (5) are mixed and stirred into A, and then mixed with B.
D(6)〜(8)を溶解してCに添加する。Dissolve D(6) to (8) and add to C.
EDに(10)、(11)を添加、混合する。Add (10) and (11) to ED and mix.
実施例[4] カラミンローション
(処方) (重量%)(1)
無水ケイ酸 0.35(2)カ
オリン 0.2(3)酸化亜
鉛 0.3(4)軽質炭酸カル
シウム 0.9(5)ベンガラ
0.002(8) 1.3−ブチレ
ングリコール 3.0(7)エチルアルコー
ル 12.0(8)香料
0.15(9)ピロリドンカルボン酸
0.1(10)大豆レシチン
0.01(11)ヒアノυロン酸−蛋白複
合体 0.01(12)塩化ナトリウム
0.8(13)塩化カリウム
0.02(14)塩化カルシウム
0.02(15)塩化マグネシウム
0.005/TON lj−基龜 ↓
琳 m L II ^ r
I’1
l(17)リン酸二水素ナトリウム 0.0
04(1日)精製水 残量(
製法)
A (12)〜(17)を(18)に溶解する。Example [4] Calamine lotion (prescription) (wt%) (1)
Silicic anhydride 0.35 (2) Kaolin 0.2 (3) Zinc oxide 0.3 (4) Light calcium carbonate 0.9 (5) Red iron
0.002(8) 1.3-butylene glycol 3.0(7) Ethyl alcohol 12.0(8) Fragrance
0.15 (9) Pyrrolidone carboxylic acid 0.1 (10) Soybean lecithin
0.01(11) Hyanoυuronic acid-protein complex 0.01(12) Sodium chloride
0.8(13) Potassium chloride
0.02(14) Calcium chloride
0.02(15) Magnesium chloride
0.005/TON lj-base ↓
Rin m L II ^ r
I'1
l(17) Sodium dihydrogen phosphate 0.0
04 (1st day) Purified water remaining amount (
Manufacturing method) A Dissolve (12) to (17) in (18).
B (10)を(8)に溶解する。B Dissolve (10) in (8).
C(1)〜(5) 、 (7)〜(9)をAに混合攪拌
し、Bと混合する。C(1) to (5) and (7) to (9) are mixed and stirred into A, and then mixed with B.
DCに(11)を添加、混合する。Add (11) to DC and mix.
上記の如くして得られた実施例 〔21〜[41の化粧
料は、いずれも保湿効果に優れ、使用感も良いものであ
った・
[発明の効果]
以上詳述した如く、本発明は、ムコ多糖類と、リン脂質
と、無機塩類とを必須に含有することにより、これらの
成分の作用効果が相乗的に発揮された新規な化粧料を提
供するものである。Examples obtained as described above [Cosmetics Nos. 21 to 41 were all excellent in moisturizing effect and felt good when used. [Effects of the Invention] As detailed above, the present invention By essentially containing mucopolysaccharides, phospholipids, and inorganic salts, the present invention provides a novel cosmetic in which the effects of these components are synergistically exhibited.
すなわち、本発明により、従来になく顕著な保湿効果を
有し、皮膚の保護と水分の保持性に優れた、極めて有用
な化粧料の提供が可能となっだのである。That is, the present invention has made it possible to provide an extremely useful cosmetic that has an unprecedented moisturizing effect and is excellent in skin protection and moisture retention.
以 上 出願人 株式会社 小林コーセーthat's all Applicant: Kobayashi Kose Co., Ltd.
Claims (1)
含有することを特徴とする化粧料。(1) A cosmetic that essentially contains mucopolysaccharides, phospholipids, and inorganic salts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61053373A JPH07116010B2 (en) | 1986-03-10 | 1986-03-10 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61053373A JPH07116010B2 (en) | 1986-03-10 | 1986-03-10 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62209010A true JPS62209010A (en) | 1987-09-14 |
JPH07116010B2 JPH07116010B2 (en) | 1995-12-13 |
Family
ID=12941011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61053373A Expired - Fee Related JPH07116010B2 (en) | 1986-03-10 | 1986-03-10 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07116010B2 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6339808A (en) * | 1986-08-05 | 1988-02-20 | Risuburan Prod:Kk | Cosmetic composition containing mineral components |
JPH01238512A (en) * | 1988-03-18 | 1989-09-22 | Sansho Seiyaku Co Ltd | Drug for external use |
JPH02178211A (en) * | 1988-12-28 | 1990-07-11 | Sansho Seiyaku Co Ltd | Stable external base composition |
EP0387252A1 (en) * | 1987-08-25 | 1990-09-19 | Macnaught Pty Ltd | Lubricant composition for rheumatism. |
EP0419148A2 (en) * | 1989-09-20 | 1991-03-27 | Shiseido Company Limited | Cosmetic composition |
JPH04235111A (en) * | 1991-01-11 | 1992-08-24 | Kyowa Hakko Kogyo Co Ltd | Cosmetic |
JPH06157283A (en) * | 1992-07-24 | 1994-06-03 | Unilever Nv | Use of cosmetics composition |
JP2008531682A (en) * | 2005-02-28 | 2008-08-14 | ソンヒョン チェ | Compositions that reduce leaching of serum proteins |
JP2017178876A (en) * | 2016-03-31 | 2017-10-05 | 花王株式会社 | Skin care methods |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59130206A (en) * | 1982-12-28 | 1984-07-26 | Kobayashi Kooc:Kk | Preparation of cosmetic |
JPS6069012A (en) * | 1983-08-02 | 1985-04-19 | ブレンダツクス−ベルケ ア−ル.シユナイダ− ゲゼルシヤフト ミツト ベシユレンクテル ハフツンク ウント コンパニ− | Skin care composition |
JPS6245336A (en) * | 1985-08-21 | 1987-02-27 | Toyo Biyuut Kk | Emulsified composition |
-
1986
- 1986-03-10 JP JP61053373A patent/JPH07116010B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59130206A (en) * | 1982-12-28 | 1984-07-26 | Kobayashi Kooc:Kk | Preparation of cosmetic |
JPS6069012A (en) * | 1983-08-02 | 1985-04-19 | ブレンダツクス−ベルケ ア−ル.シユナイダ− ゲゼルシヤフト ミツト ベシユレンクテル ハフツンク ウント コンパニ− | Skin care composition |
JPS6245336A (en) * | 1985-08-21 | 1987-02-27 | Toyo Biyuut Kk | Emulsified composition |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6339808A (en) * | 1986-08-05 | 1988-02-20 | Risuburan Prod:Kk | Cosmetic composition containing mineral components |
EP0387252A1 (en) * | 1987-08-25 | 1990-09-19 | Macnaught Pty Ltd | Lubricant composition for rheumatism. |
JPH01238512A (en) * | 1988-03-18 | 1989-09-22 | Sansho Seiyaku Co Ltd | Drug for external use |
JPH02178211A (en) * | 1988-12-28 | 1990-07-11 | Sansho Seiyaku Co Ltd | Stable external base composition |
EP0419148A2 (en) * | 1989-09-20 | 1991-03-27 | Shiseido Company Limited | Cosmetic composition |
JPH04235111A (en) * | 1991-01-11 | 1992-08-24 | Kyowa Hakko Kogyo Co Ltd | Cosmetic |
JPH06157283A (en) * | 1992-07-24 | 1994-06-03 | Unilever Nv | Use of cosmetics composition |
JP2008531682A (en) * | 2005-02-28 | 2008-08-14 | ソンヒョン チェ | Compositions that reduce leaching of serum proteins |
JP2012188434A (en) * | 2005-02-28 | 2012-10-04 | Seong-Hyun Choi | Composition for reducing serum protein leaching |
US8853195B2 (en) | 2005-02-28 | 2014-10-07 | Kt & G Corporation | Composition for reducing the exudation of serum proteins |
JP2017178876A (en) * | 2016-03-31 | 2017-10-05 | 花王株式会社 | Skin care methods |
Also Published As
Publication number | Publication date |
---|---|
JPH07116010B2 (en) | 1995-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100411837B1 (en) | Preparations and methods for reducing skin irritation | |
CA2264877C (en) | Lip treatment containing live yeast cell derivative | |
US6579516B1 (en) | Methods of delivering materials into the skin, and compositions used therein | |
US20010006680A1 (en) | Skin care moisturizers and cleansers | |
JP7307835B2 (en) | aqueous composition | |
US6248340B1 (en) | Skin care and protection composition and a method for preparation thereof | |
JPH05504757A (en) | skin care preparations | |
JPH08501553A (en) | Skin conditioning composition, its application and manufacture | |
MXPA97004778A (en) | Formulations to reduce skin irritations and use of mis | |
JPH03505872A (en) | Cosmetic and skin treatment compositions | |
JPS62209010A (en) | Cosmetic | |
KR20050103903A (en) | Topical composition and methods for treatment of aged or environmentally damaged skin | |
JPH06104620B2 (en) | Skin cosmetics | |
JP2001131049A (en) | Skin preparation for external use | |
JPH0623088B2 (en) | Cosmetics | |
JPS62209009A (en) | Cosmetic | |
JPH09268119A (en) | Preparation for external use for skin | |
JPH11139951A (en) | Cosmetic | |
JPS60116618A (en) | Cosmetic | |
JPH0696514B2 (en) | Skin cosmetics | |
JP3507635B2 (en) | Composition suitable for external use | |
JPH03112912A (en) | Cosmetic composition | |
JPS6277308A (en) | Cosmetic | |
WO1997027837A1 (en) | New chemical mixtures with excellent microbicide, fungicide, and virucide effects; preparation methods, and use | |
JPH04134012A (en) | Sebum secretion promoter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |